Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2pml | ANP | Uncharacterized protein |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 2pml | ANP | Uncharacterized protein | / | 1.000 | |
| 1zth | ADP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.486 | |
| 2pmo | HMD | Protein kinase 7 | / | 0.486 | |
| 3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.486 | |
| 4oa9 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.480 | |
| 2pmn | K51 | Protein kinase 7 | / | 0.459 | |
| 3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
| 2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
| 4i3z | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
| 2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.450 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.450 | |
| 1jst | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.448 | |
| 2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 4gvj | ADP | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.445 | |
| 4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.445 | |
| 4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.443 | |
| 5e92 | ANP | TGF-beta receptor type-2 | 2.7.11.30 | 0.442 | |
| 2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
| 2pz5 | ACP | Fibroblast growth factor receptor 2 | / | 0.441 |